https://sputnikglobe.com/20211005/russias-sputnik-v-vaccine-developer-hopes-to-receive-who-approval-before-2022-1089682789.html
Russia's Sputnik V Vaccine Developer Hopes to Receive WHO Approval Before 2022
Russia's Sputnik V Vaccine Developer Hopes to Receive WHO Approval Before 2022
Sputnik International
NOVOSIBIRSK (Sputnik) – The developer of the Russian Sputnik V COVID-19 vaccine, Gamaleya research institute, hopes that the drug will receive necessary... 05.10.2021, Sputnik International
2021-10-05T13:07+0000
2021-10-05T13:07+0000
2021-10-05T13:08+0000
russia
vaccine
covid-19
sputnik v vaccine
https://cdn1.img.sputnikglobe.com/img/07e5/07/08/1083333351_0:160:3073:1888_1920x0_80_0_0_8f137779176dc6019a7992a000bebaff.jpg
"I believe it will happen in the coming months, October or November. I think we will end this year with the vaccine being finally recognized by the WHO," Gushchin said at the OPENBIO biotechnology forum.He noted that the WHO approval is the current priority of the institute and the Russian Direct Investment Fund (RDIF), which has been heavily involved in the production, clinical research, and registration of Sputnik V with relevant authorities.Gushchin added that he had expected the vaccine to gain approval in September, as the WHO earlier announced, but that did not happen.Sputnik V is currently authorized for use in 70 countries with a total population of four billion people, or 50% of the world's population.
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
vaccine, covid-19, sputnik v vaccine
vaccine, covid-19, sputnik v vaccine
Russia's Sputnik V Vaccine Developer Hopes to Receive WHO Approval Before 2022
13:07 GMT 05.10.2021 (Updated: 13:08 GMT 05.10.2021) NOVOSIBIRSK (Sputnik) – The developer of the Russian Sputnik V COVID-19 vaccine, Gamaleya research institute, hopes that the drug will receive necessary approval from the World Health Organization (WHO) by the end of the year, Vladimir Gushchin, a senior researcher at the institute, said on Tuesday.
"I believe it will happen in the coming months, October or November. I think we will end this year with the vaccine being finally recognized by the WHO," Gushchin said at the OPENBIO biotechnology forum.
He noted that the WHO approval is the current priority of the institute and the Russian Direct Investment Fund (RDIF), which has been heavily involved in the production, clinical research, and
registration of Sputnik V with relevant authorities.
Gushchin added that he had expected the vaccine to gain approval in September, as the WHO earlier announced, but that did not happen.
Sputnik V is currently authorized for use in 70 countries with a total population of four billion people, or 50% of the world's population.
